Autor: |
Blair J N, Leonard, Deborah A, Kennedy, Fong-Chi, Cheng, Keng-Kuang, Chang, Dugald, Seely, Edward, Mills |
Rok vydání: |
2006 |
Předmět: |
|
Zdroj: |
Anticancer research. 26(4B) |
ISSN: |
0250-7005 |
Popis: |
Essiac is a herbal compound that has been in common use with cancer patients in North America for over 80 years. Despite its relatively widespread use, there are no peer-reviewed published reports of in vivo studies regarding the use of this compound.Essiac was administered orally to test animals prior to all experiments. Standard assays to test protection from ethanol-induced gastric ulceration and carbon tetrachloride-induced hepatic injury were performed on Wistar rats. Assays of postglucose-load serum glucose and cellular and humoral immune modulation were conducted on ICR and BALB/C mice, respectively.Essiac demonstrated a modest gastric protective effect via reduction of ethanol-induced gastric ulceration. However, Essiac did not demonstrate significant hepatoprotective, hypoglycemic or immunomodulatory properties.Essiac, administered in established in vivo experimental models, did not significantly demonstrate its purported physiological modifying effects. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|